Myriad Genetics, Inc. (MYGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
26.71+0.91 (+3.53%)
At close: 4:00PM EST
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 25.80 |
| Open | 25.52 |
| Bid | 25.00 x 1000 |
| Ask | 27.00 x 1000 |
| Day's Range | 25.52 - 26.99 |
| 52 Week Range | 9.24 - 30.13 |
| Volume | 806,735 |
| Avg. Volume | 776,622 |
| Market Cap | 2.009B |
| Beta (5Y Monthly) | 1.72 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Myriad Genetics (MYGN), Illumina Partner to Enhance Oncology Arm
Myriad Genetics (MYGN) partners with Illumina to expand the access as well as extend the reach of myChoice CDx through its services offering in the international market.
- TheStreet.com
Myriad Genetics Up on Strategic-Options Plan for Autoimmune Unit
Myriad Genetics stock traded higher after the diagnostic-testing company said it was pursuing strategic alternatives for its Vectra autoimmune business.
- Zacks
Why Is Myriad (MYGN) Up 8.3% Since Last Earnings Report?
Myriad (MYGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2021 Verizon Media. All rights reserved.
